LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma

Journal of Hepatology

Volumn 50, Issue 3, 2009, Pages 528-537

  Wang, Bei ^a,b   Feng, Ping ^c   Xiao, Ziwei ^b   Ren, Ee Chee ^a,b  

^a AGENCY FOR SCIENCE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

Focal adhesion plaque; Hepatocellular carcinoma; Lasp1; Metastasis; p53

Indexed keywords

LIM KINASE; PROTEIN P53; PROTEIN SH3; SMALL INTERFERING RNA;

ARTICLE; CANCER GROWTH; CANCER INVASION; CELL MIGRATION; CELL MOTILITY; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA BINDING; DNA RESPONSIVE ELEMENT; GENE CONTROL; GENE EXPRESSION REGULATION; GENE MUTATION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; METASTASIS; MICROARRAY ANALYSIS; ONCOGENE; ONCOGENE LASP 1; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DATABASE; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION; TRANSIENT TRANSFECTION; UPREGULATION; WILD TYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CARCINOMA, HEPATOCELLULAR; CYTOSKELETAL PROTEINS; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; MICROFILAMENT PROTEINS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMIDS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 59349096434     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.10.025     Document Type: Article

References (31)

1. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907-1917
2. Thomas M.B., and Zhu A.X. Hepatocellular carcinoma: the need for progress. J Clin Oncol 23 (2005) 2892-2899
3. Vousden K.H., and Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2 (2002) 594-604
4. Shu K.X., Li B., and Wu L.X. The p53 network: p53 and its downstream genes. Colloids Surf B Biointerfaces 55 (2007) 10-18
5. Mashimo T., Watabe M., Hirota S., Hosobe S., Miura K., Tegtmeyer P.J., et al. The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53. Proc Natl Acad Sci USA 95 (1998) 11307-11311
6. Zou Z., Gao C., Nagaich A.K., Connell T., Saito S., Moul J.W., et al. p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 275 (2000) 6051-6054
7. Neo S.Y., Leow C.K., Vega V.B., Long P.M., Islam A.F., Lai P.B., et al. Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach. Hepatology 39 (2004) 944-953
8. Wei C.L., Wu Q., Vega V.B., Chiu K.P., Ng P., Zhang T., et al. A global map of p53 transcription-factor binding sites in the human genome. Cell 124 (2006) 207-219
9. Tomasetto C., Regnier C., Moog-Lutz C., Mattei M.G., Chenard M.P., Lidereau R., et al. Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. Genomics 28 (1995) 367-376
10. Grunewald T.G., Kammerer U., Winkler C., Schindler D., Sickmann A., Honig A., et al. Overexpression of LASP-1 mediates migration and proliferation of human ovarian cancer cells and influences zyxin localisation. Br J Cancer 96 (2007) 296-305
11. Grunewald T.G., Kammerer U., Schulze E., Schindler D., Honig A., Zimmer M., et al. Exp Cell Res 312 (2006) 974-982
12. Tomasetto C., Moog-Lutz C., Regnier C.H., Schreiber V., Basset P., and Rio M.C. Lasp-1 (MLN 50) defines a new LIM protein subfamily characterized by the association of LIM and SH3 domains. FEBS Lett 373 (1995) 245-249
13. Chew C.S., Chen X., Parente Jr. J.A., Tarrer S., Okamoto C., and Qin H.Y. Lasp-1 binds to non-muscle F-actin in vitro and is localized within multiple sites of dynamic actin assembly in vivo. J Cell Sci 115 (2002) 4787-4799
14. Keicher C., Gambaryan S., Schulze E., Marcus K., Meyer H.E., and Butt E. Phosphorylation of mouse LASP-1 on threonine 156 by cAMP- and cGMP-dependent protein kinase. Biochem Biophys Res Commun 324 (2004) 308-316
15. Okamoto C.T., Li R., Zhang Z., Jeng Y.Y., and Chew C.S. Regulation of protein and vesicle trafficking at the apical membrane of epithelial cells. J Control Release 78 (2002) 35-41
16. Spence H.J., McGarry L., Chew C.S., Carragher N.O., Scott-Carragher L.A., Yuan Z., et al. Mol Cell Biol 26 (2006) 1480-1495
17. Feng P., Wang B., and Ren E.C. Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response. Int J Biochem Cell Biol 40 (2008) 98-109
18. Chen H.C. Boyden chamber assay. Methods Mol Biol 294 (2005) 15-22
19. Cheng G.Z., Chan J., Wang Q., Zhang W., Sun C.D., and Wang L.H. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 67 (2007) 1979-1987
20. Lin Y.H., Park Z.Y., Lin D., Brahmbhatt A.A., Rio M.C., Yates III J.R., et al. Regulation of cell migration and survival by focal adhesion targeting of Lasp-1. J Cell Biol 165 (2004) 421-432
21. el-Deiry W.S., Kern S.E., Pietenpol J.A., Kinzler K.W., and Vogelstein B. Definition of a consensus binding site for p53. Nat Genet 1 (1992) 45-49
22. Longley D.B., Harkin D.P., and Johnston P.G. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 3 (2003) 330-338
23. Pan Y., and Nussinov R. Structural basis for p53 binding-induced DNA bending. J Biol Chem 282 (2007) 691-699
24. Ho J., and Benchimol S. Transcriptional repression mediated by the p53 tumour suppressor. Cell Death Differ 10 (2003) 404-408
25. Dearth L.R., Qian H., Wang T., Baroni T.E., Zeng J., Chen S.W., et al. Inactive full-length p53 mutants lacking dominant wild-type p53 inhibition highlight loss of heterozygosity as an important aspect of p53 status in human cancers. Carcinogenesis 28 (2007) 289-298
26. Kawamura M., Yamashita T., Segawa K., Kaneuchi M., Shindoh M., and Fujinaga K. The 273rd codon mutants of p53 show growth modulation activities not correlated with p53-specific transactivation activity. Oncogene 12 (1996) 2361-2367
27. rias-Lopez C., Lazaro-Trueba I., Kerr P., Lord C.J., Dexter T., Iravani M., et al. p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene. EMBO Rep 7 (2006) 219-224
28. Butt E., Gambaryan S., Gottfert N., Galler A., Marcus K., and Meyer H.E. Actin binding of human LIM and SH3 protein is regulated by cGMP- and cAMP-dependent protein kinase phosphorylation on serine 146. J Biol Chem 278 (2003) 15601-15607
29. Li B., Zhuang L., and Trueb B. Zyxin interacts with the SH3 domains of the cytoskeletal proteins LIM-nebulette and Lasp-1. J Biol Chem 279 (2004) 20401-20410
30. Schreiber V., Moog-Lutz C., Regnier C.H., Chenard M.P., Boeuf H., Vonesch J.L., et al. Lasp-1, a novel type of actin-binding protein accumulating in cell membrane extensions. Mol Med 4 (1998) 675-687
31. Grunewald T.G., and Butt E. The LIM and SH3 domain protein family: structural proteins or signal transducers or both?. Mol Cancer 7 (2008) 31